CD226 and neoplasm: Although blockade of ICAM-1/LFA-1 interaction, using anti-ICAM-1 mAbs, did not alter the extent of tumor lysis, blocking NKG2D and DNAM-1 alone, or in combination, significantly lowered NK cytotoxicity up to 70% (Figure 5B, left).